The Ranitidine Injection, cataloged under National Stock Number 6505-01-206-0278, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxo Wellcome Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-206-0278 |
| Primary Part Number | NDC00173-0363-39 |
| Item Name | Ranitidine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxo Wellcome Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 10.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS RANITIDINE EQUIVALENT PER MILLILITER |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00173-0363-39 PRIMARY | Glaxo Wellcome Inc (USA) |
| Reference | Meaning |
|---|---|
| ZANTAC INJECTION | 5/1 Secondary reference Glaxo Wellcome Inc |
| ZANTAC | 5/1 Secondary reference Glaxo Wellcome Inc |
NSN 6505-01-206-0278 is a Ranitidine Injection, manufactured by Glaxo Wellcome Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-206-0278 has 1 manufacturer part number on file: NDC00173-0363-39 (Glaxo Wellcome Inc).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-371-7070. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00173-0363-39: Primary Container Content Quantity: 10.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL, MULTIPLE DOSE; Active Medicament Medicinal Strength: 25.000 MILLIGRAMS RANITIDINE EQUIVALENT PER MILLILITER. 4 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.